Study guide
6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia
Veterinary Technician Specialist in Emergency and Critical Care VTS ECC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Triage & Point-of-Care Assessment
1.1 AVECCTN Examination Structure, Blueprint & Credentialing 1.2 Emergency Triage Systems, Primary Survey & Capsule Diagnostics 1.3 Point-of-Care Ultrasound (POCUS / TFAST / AFAST / VetBLUE) & Rapid Interventions
2 Chapter 2: Cardiovascular Emergencies & RECOVER CPR
2.1 RECOVER Guidelines: Basic Life Support (BLS) & Resuscitation Dynamics 2.2 Advanced Life Support (ALS): Emergency Pharmacopeia, Reversals & Defibrillation 2.3 Electrocardiogram (ECG) Interpretation & Antiarrhythmic Therapy 2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism
3 Chapter 3: Fluid Therapy, Shock Resuscitation & Acid-Base Balance
3.1 Pathophysiology, Stages & Classification of Shock 3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation 3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus 3.4 Arterial & Venous Blood Gas Analysis & Acid-Base Disorders
4 Chapter 4: Respiratory Emergencies & Mechanical Ventilation
4.1 Upper Airway Obstruction: BOAS, Laryngeal Paralysis & Tracheal Collapse 4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS 4.3 Pleural Space Disease, Emergency Thoracocentesis & Chest Tube Management 4.4 Oxygen Delivery Modalities, Capnography & Mechanical Ventilation Basics
5 Chapter 5: Gastrointestinal & Hepatic Emergencies
5.1 Gastric Dilatation-Volvulus (GDV): Resuscitation, Decompression & Critical Nursing 5.2 Acute Abdomen, Septic Peritonitis & Canine Parvoviral Enteritis 5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus 5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies
6 Chapter 6: Anesthesia, Analgesia & Constant Rate Infusions
6.1 Emergency Anesthesia Protocols & High-Risk Patient Stabilization 6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia 6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring 6.4 Anesthetic Complications: Hypotension, Hypothermia & Emergency Interventions
7 Chapter 7: Renal & Urinary Emergencies
7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy 7.2 Feline Urethral Obstruction: Deobstruction, Electrolyte Crises & Post-Obstructive Diuresis 7.3 Uroabdomen & Lower Urinary Tract Trauma: Diagnosis & Resuscitation
8 Chapter 8: Hemolymphatic, Transfusion Medicine & Sepsis/SIRS
8.1 Transfusion Medicine: Blood Typing, Crossmatching & Component Therapy 8.2 Immune-Mediated Hemolytic Anemia (IMHA) & Immune-Mediated Thrombocytopenia (IMTP) 8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC 8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia
9 Chapter 9: Environmental, Toxicological, Ophthalmic & Exotic Species Emergencies
9.1 Heatstroke, Severe Hypothermia & Thermal Burn Management 9.2 Envenomation Syndromes & Acute Anaphylaxis Management 9.3 Common Small Animal Toxicities: Chocolate, Xylitol, NSAIDs & Rodenticides 9.4 Neurotoxins, Ethylene Glycol, Plant Toxins & Extracorporeal Therapies 9.5 Ophthalmologic Emergencies: Proptosis, Acute Glaucoma, Corneal Perforation & Chemical Injury 9.6 Emergency Care of Exotic Companion Species: Rabbits, Rodents, Ferrets, Birds & Reptiles
10 Chapter 10: Neurological Emergencies
10.1 Status Epilepticus & Cluster Seizures: Emergency Protocols & Refractory Therapy 10.2 Traumatic Brain Injury (TBI), Intracranial Pressure (ICP) & Modified Glasgow Coma Scale 10.3 Acute Spinal Cord Emergencies: Intervertebral Disc Disease (IVDD) & Neuro-Localization
11 Chapter 11: Endocrine & Metabolic Crises
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Acute Adrenocortical Crisis (Addisonian Crisis) & Hypoadrenocorticism 11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia
12 Chapter 12: Reproductive & Musculoskeletal Emergencies
12.1 Reproductive Emergencies: Dystocia, Pyometra & Puerperal Hypocalcemia 12.2 Musculoskeletal Trauma: Open Fractures, Luxations, Splints & Compartment Syndrome 12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation
13 Chapter 13: Advanced Critical Care Monitoring, Vascular Access & The Rule of 20
13.1 Central Venous Catheterization, Arterial Lines & Intraosseous Access 13.2 Hemodynamic Monitoring: Invasive vs. Non-Invasive Blood Pressure, CVP & Cardiac Output 13.3 Kirby's Rule of 20: Comprehensive Daily Critical Patient Evaluation Checklist
6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia
Key Takeaways Explain This Topic AI
Nociception consists of four distinct physiological phases—Transduction, Transmission, Modulation, and Perception—each modulated by different pharmacological drug classes to achieve balanced multimodal analgesia.
Repetitive, unmitigated C-fiber nociceptive input to the dorsal horn of the spinal cord removes the resting magnesium block from post-synaptic NMDA receptors, triggering the 'wind-up' phenomenon, hyperalgesia, and allodynia.
Validated veterinary pain scales, such as the Glasgow Composite Measure Pain Scale Short Form (CMPS-SF, intervention threshold score ≥ 6/24 or ≥ 5/20 in non-ambulatory dogs) and the Colorado State University (CSU) pain scales, provide objective clinical thresholds for analgesic rescue.
Subanesthetic NMDA receptor antagonists (Ketamine CRI 2-10 mcg/kg/min) and low-dose alpha-2 agonists (Dexmedetomidine micro-infusions) prevent spinal dorsal horn central sensitization and provide profound opioid-sparing analgesia.
Local and regional nerve blocks (Epidural, Transversus Abdominis Plane [TAP], Intercostal, and Dental nerve blocks) completely block sodium channels (NaV) and interrupt transmission of noxious stimuli at the source, dramatically reducing systemic drug requirements.
Last updated: August 2026
Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia
VTS Core Concept: Pain is not merely an uncomfortable sensation—untreated acute pain is a destructive systemic pathology. Pain induces severe neuroendocrine stress responses: massive endogenous catecholamine release, tachycardia, systemic vasoconstriction, hypermetabolism, protein catabolism, immunosuppression, impaired wound healing, and central nervous system remodeling. Multimodal analgesia—targeting multiple distinct points along the nociceptive pathway—is the cornerstone of emergency and critical care nursing.
1. The Physiology of Nociception
Nociception is the physiological process by which noxious thermal, mechanical, or chemical stimuli are detected, transmitted, and processed by the nervous system. It consists of four distinct phases: [ Noxious Stimulus ]
- │
- ▼
1. TRANSDUCTION ───► Peripheral nociceptors (A-delta & C fibers) convert stimulus into electrical action potentials
- │
- ▼
- 2. TRANSMISSION ───► Action potentials propagate along peripheral nerves to the dorsal horn of the spinal cord
- │
- ▼
- 3. MODULATION ───► Spinal dorsal horn interneurons amplify or inhibit signals (Substance P, Glutamate, NMDA)
- │
- ▼
4. PERCEPTION ───► Thalamus and cerebral cortex process signals into the conscious, emotional experience of PAIN
The Four Phases and Pharmacological Targets
Nociceptive Phase Anatomical Location & Mechanism Primary Nerve Fibers Involved Target Analgesic Drug Classes
1. Transduction Peripheral tissues (skin, viscera, periosteum). Noxious mechanical/thermal/chemical energy converted to depolarization A-delta fibers (myelinated, fast, sharp/localized pain) & C fibers (unmyelinated, slow, dull/throbbing pain) Local anesthetics (Lidocaine, Bupivacaine), NSAIDs, Corticosteroids, Cold therapy (Cryotherapy)
2. Transmission Peripheral sensory nerves -> Dorsal root ganglion -> Spinal cord dorsal horn Sensory nerve trunks Local anesthetics (Nerve blocks, Epidural), alpha-2-Adrenergic agonists
3. Modulation Dorsal horn of the spinal cord (Rexed laminae I, II, V). Endogenous inhibitory neurotransmitters (GABA, glycine, endorphins) vs. excitatory amplification (Glutamate, Substance P) Dorsal horn projection neurons and interneurons Opioids, NMDA antagonists (Ketamine, Amantadine), alpha-2-Agonists (Dexmedetomidine), Gabapentin, TCAs
4. Perception Brainstem, Thalamus, Somatosensory Cortex, and Limbic system. Conscious emotional and cognitive recognition of pain Ascending spinothalamic tracts -> Cerebral cortex Pure mu-Opioids, Inhalant anesthetics, alpha-2-Agonists, Benzodiazepines, General anesthetics
Loading diagram... The Four Phases of Nociception and Targeted Multimodal Pharmacology
2. Central Sensitization & The "Wind-Up" Phenomenon
When surgical trauma or tissue inflammation generates severe, repetitive, uninhibited C-fiber nociceptive volleys into the dorsal horn of the spinal cord, a profound neuroplastic alteration occurs known as central sensitization (or the "wind-up" phenomenon ):
Glutamate Release: Intense nociceptive input causes massive presynaptic release of excitatory amino acids ( Glutamate ) and neuropeptides ( Substance P ).
Removal of Magnesium Block: Under resting conditions, post-synaptic N-methyl-D-aspartate (NMDA) receptor channels are blocked by a resting magnesium (Mg2+) ion. Sustained membrane depolarization by glutamate acting at AMPA receptors expels the Mg2+ plug from the NMDA receptor pore.
Calcium Influx & Second Messengers: Unblocked NMDA receptors allow a massive influx of intracellular calcium (Ca2+), activating protein kinase C (PKC), nitric oxide synthase (NOS), and cyclooxygenase-2 (COX-2) gene transcription.
Hyperexcitability & Receptive Field Expansion: Dorsal horn wide dynamic range (WDR) neurons become profoundly hyperexcitable, firing in response to sub-threshold inputs.
Clinical Manifestations of Central Sensitization
Primary Hyperalgesia: Exaggerated pain response to normally painful stimuli at the site of tissue injury.
Secondary Hyperalgesia: Pain sensitivity expanding into undamaged, healthy surrounding tissue.
Allodynia: Pain evoked by normally non-noxious, innocuous stimuli (such as light touch, gentle palpation, or air movement).
Opioid Resistance: Established wind-up requires dramatically escalating doses of opioids to achieve clinical comfort, frequently producing dysphoria and side effects without pain relief. Subanesthetic Ketamine (0.1-0.5 mg/kg IV bolus, followed by 2-10 mcg/kg/min CRI) directly blocks open NMDA receptor channels, "unwinding" central sensitization and restoring opioid receptor sensitivity.
3. Validated Veterinary Pain Scoring Scales
Pain assessment in veterinary patients requires systematic, validated behavioral evaluation tools rather than subjective guesswork.
1. Glasgow Composite Measure Pain Scale Short Form (CMPS-SF)
The Glasgow CMPS-SF is a validated behavioral assessment tool for acute pain in dogs. It evaluates 6 categories comprising 30 behavioral descriptions:
Evaluated Categories: (1) Vocalization, (2) Attention to wound/surgical site, (3) Demeanor/responsiveness, (4) Mobility/gait, (5) Posture, and (6) Response to gentle palpation around the wound.
Scoring Scale: Total maximum score of 24 for ambulatory dogs (or 20 for non-ambulatory dogs).
Analgesic Intervention Threshold:
For ambulatory dogs: Score >= 6 / 24 mandates immediate analgesic intervention/rescue.
For non-ambulatory dogs: Score >= 5 / 20 mandates immediate analgesic intervention/rescue.
2. Colorado State University (CSU) Pain Scales (Canine & Feline)
The CSU Pain Scale uses a 0 to 4 numerical rating scale integrated with behavioral descriptions and anatomical diagrams:
Score 0 (No Pain): Happy, content, relaxed body posture, interactive, non-reactive to wound palpation.
Score 1 (Mild Pain): Mildly quiet or restless, subtle facial tension, whimpering/withdrawing slightly on firm wound palpation.
Score 2 (Moderate Pain): Drooped head, looking at or licking wound, guarding affected area, vocalizing on palpation, tense abdomen.
Score 3 (Severe Pain): Depressed, reluctant to move, groaning, vocalizing, dramatic guarding or flinching upon palpation, glazed expression.
Score 4 (Excruciating Pain): Prostrate, thrashing, screaming/crying, completely unresponsive to human contact, extreme aggression on approach.
Intervention Threshold: Any score of >= 2 / 4 warrants reassessment and immediate analgesic rescue.
3. Feline Grimace Scale (FGS)
The Feline Grimace Scale evaluates 5 facial action units (ear position, orbital tightening, muzzle tension, whisker position, and head position), scored from 0 (absent) to 2 (markedly present) with a maximum total of 10. An overall score of >= 4 / 10 (or >= 0.39 normalized) indicates that the cat requires analgesic rescue.
- 4. Systemic Multimodal Analgesic Pharmacology
- 1. Opioid Class Dynamics
Pure mu-Agonists (Morphine, Hydromorphone, Methadone, Fentanyl): Provide maximum efficacy for moderate-to-severe somatic and visceral pain. No analgesic "ceiling effect."
Partial mu-Agonists (Buprenorphine 0.01-0.03 mg/kg IV/IM/OTM): Extremely high binding affinity for mu-receptors but lower intrinsic efficacy. Possesses an analgesic ceiling effect —increasing the dose beyond therapeutic range does not produce additional analgesia. Excellent for mild-to-moderate feline pain (transmucosal OTM absorption). Clinical Warning: Due to its near-irreversible binding affinity, buprenorphine will displace pure mu-agonists and block their efficacy if emergency rescue analgesia is needed.
kappa-Agonists / mu-Antagonists (Butorphanol 0.1-0.4 mg/kg IV/IM): Stimulates kappa receptors (mild visceral sedation/analgesia) while antagonizing mu receptors. Has a short duration of analgesia (45-90 minutes) and poor somatic pain efficacy. Useful for non-painful diagnostic sedation or as a partial reversal agent for opioid-induced dysphoria/respiratory depression while maintaining mild kappa analgesia.
2. Alpha-2 Adrenergic Agonists (Dexmedetomidine)
Acts at presynaptic alpha-2-receptors in the locus coeruleus (sedation) and dorsal horn substantia gelatinosa (analgesia). Micro-doses (0.5-1.0 mcg/kg IV) provide potent opioid-sparing analgesia and smooth emergence delirium without catastrophic vasoconstriction.
3. Local Anesthetics (Sodium Channel Blockers)
Reversibly bind to the intracellular pore of voltage-gated sodium channels (NaV), preventing sodium influx and completely abolishing action potential generation.
Lidocaine: Rapid onset (2-5 min), duration 1-2 hours. Safe for systemic IV CRI in dogs.
Bupivacaine (0.25-0.5%): Slow onset (15-20 min), long duration (4-8 hours). STRICTLY CONTRAINDICATED FOR INTRAVENOUS USE. IV injection causes catastrophic, refractory myocardial conduction blockade and cardiovascular collapse. Toxicity Treatment: 20% Intravenous Lipid Emulsion (ILE) (1.5 mL/kg bolus followed by 0.25 mL/kg/min CRI).
Ropivacaine (0.5-0.75%): S-enantiomer, duration 4-6 hours. Significantly less cardiotoxic than bupivacaine; preferentially blocks sensory fibers over motor fibers.
4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Inhibit Cyclooxygenase (COX-1/COX-2), blocking the conversion of arachidonic acid to inflammatory prostaglandins (PGE2).
Critical ECC Warning: NSAID Contraindications
NSAIDs are strictly contraindicated in the emergency/trauma setting when any of the following exist:
Hypovolemia, Hypotension (MAP < 60 mmHg), or Dehydration (blocks renal prostaglandins PGE2/PGI2, triggering severe renal medullary ischemia and acute tubular necrosis)
- Acute Kidney Injury (AKI) or Chronic Renal Disease
- Gastrointestinal Ulceration, Hemorrhage, or Septic Peritonitis
Concurrent Corticosteroid Therapy (requires a mandatory 5-7 day washout period to avoid catastrophic GI perforation)
5. Regional and Local Anesthesia Techniques in Critical Care
Regional anesthesia blocks nociceptive transmission at the level of peripheral nerve trunks or the spinal cord, achieving complete desensitization of the surgical field.
Regional Technique Anatomical Landmarks & Procedure Target Innervation Blocked Clinical ECC Indications & Safety Warnings
Epidural Anesthesia Lumbosacral junction ( L7-S1 ). Palpate dorsal cranial iliac wings, L7 spinous process, and sacral crest. Insert spinal needle perpendicular; verify "pop" through ligamentum flavum, confirm negative aspiration for blood/CSF, and confirm "hanging drop" suction Bilateral sensory and motor blockade from T13/L1 caudally (hindlimbs, pelvis, perineum, tail) Caudal abdominal surgery, pelvic/femur fractures, urethral obstruction. Drugs: Preservative-free Morphine (0.1 mg/kg) ± Bupivacaine 0.5% (0.5-1.0 mg/kg). Contraindications: Sepsis/bacteremia, coagulopathy/thrombocytopenia, pelvic trauma obscuring landmarks, local pyoderma
Transversus Abdominis Plane (TAP) Block Ultrasound-guided interfascial block. Needle placed between the Internal Abdominal Oblique and Transversus Abdominis muscles; deposit local anesthetic bilaterally Ventral abdominal wall sensory nerves (T9-L3) Major exploratory celiotomy, GDV, septic peritonitis, cesarean section. Highly effective somatic analgesia without motor blockade or sympathetic tone loss
Intercostal Nerve Block Deposit local anesthetic at the caudal border of the rib where the neurovascular bundle (intercostal artery, vein, and nerve) travels subcostally Intercostal somatic nerves supplying chest wall and parietal pleura Thoracotomy incisions, rib fractures, thoracostomy (chest) tube placement. Technique Rule: Block the target rib space plus at least 2 spaces cranial and 2 spaces caudal . Always aspirate before injection to prevent intravascular injection
Dental & Maxillofacial Blocks - Infraorbital: Rostral maxilla, canines, incisors; - Maxillary: Caudal to 2nd molar; entire ipsilateral maxillary quadrant; - Inferior Alveolar (Mandibular): Mandibular foramen; entire mandibular quadrant; - Mental: Middle mental foramen; rostral mandible Specific branches of the Trigeminal Nerve (CN V) Maxillofacial trauma, mandibulectomy/maxillectomy, jaw fractures, severe dental abscesses. Warning: Inferior alveolar block can cause tongue desensitization; monitor post-op to prevent self-mutilation